Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.45 is 16% below its 5-year average of 12.51, near the low end of its 5-year range (4.50–28.42).
As of the fiscal period ended Tuesday, June 30, 2026. 8.90% below its 12-month average of 11.47.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.45.
CURRENT RATIO
10.45
CURRENT RATIO AVG TTM
11.47
CURRENT RATIO AVG 3Y
16.46
CURRENT RATIO AVG 5Y
12.51
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.90%
CURRENT VS 3Y AVG
-36.49%
CURRENT VS 5Y AVG
-16.48%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 759 covered companies
CURRENT VS SECTOR MEDIAN
+191.10%
vs the sector median at left
IDEAYA Biosciences, Inc.
Market Cap
$3.51B
Current Ratio
10.45
TTM Avg
11.47
3Y Avg
16.46
5Y Avg
12.51
Market Cap
$3.53B
Current Ratio
3.87
TTM Avg
5.22
3Y Avg
3.96
5Y Avg
4.18
Market Cap
$3.56B
Current Ratio
1.42
TTM Avg
24.66
3Y Avg
24.23
5Y Avg
16.18
Market Cap
$3.41B
Current Ratio
3.39
TTM Avg
3.10
3Y Avg
3.17
5Y Avg
4.31
Market Cap
$3.35B
Current Ratio
17.91
TTM Avg
1.68
3Y Avg
1.68
5Y Avg
1.68
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | $3.51B | 10.45 | 11.47 | 16.46 | 12.51 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.53B | 3.87 | 5.22 | 3.96 | 4.18 |
| Celcuity Inc. (CELC)vs › | $3.50B | 8.93 | 9.13 | 14.29 | 16.91 |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.56B | 1.42 | 24.66 | 24.23 | 16.18 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.41B | 3.39 | 3.10 | 3.17 | 4.31 |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.40B | 9.63 | 11.21 | 9.89 | 7.80 |
| CareDx, Inc (CDNA)vs › | $3.39B | 4.58 | 3.40 | 3.98 | 4.25 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.35B | 17.91 | 1.68 | 1.68 | 1.68 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.12B | 8.37 | 8.81 | 8.76 | 9.71 |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.05B | 2.92 | 3.66 | 6.49 | 8.50 |
Current Ratio
10.45
Quick Ratio
10.45
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.45 |
| 2026-03-31 | 10.74 |
| 2025-12-31 | 11.34 |
| 2025-09-30 | 12.44 |
| 2025-06-30 | 12.39 |
| 2025-03-31 | 13.92 |
| 2024-12-31 | 14.97 |
| 2024-09-30 | 22.93 |
| 2024-06-30 | 17.50 |
| 2024-03-31 | 28.42 |
| 2023-12-31 | 19.65 |
| 2023-09-30 | 19.37 |
| 2023-06-30 | 19.80 |
| 2023-03-31 | 11.53 |
| 2022-12-31 | 11.68 |
| 2022-09-30 | 12.02 |
| 2022-06-30 | 4.69 |
| 2022-03-31 | 4.50 |
| 2021-12-31 | 5.56 |
| 2021-09-30 | 6.96 |
| 2021-06-30 | 7.82 |
| 2021-03-31 | 8.53 |
| 2020-12-31 | 7.47 |
| 2020-09-30 | 5.19 |
| 2020-06-30 | 23.42 |
| 2020-03-31 | 12.18 |
| 2019-12-31 | 14.65 |
| 2019-09-30 | 18.86 |
| 2019-06-30 | 18.95 |
| 2019-03-31 | 13.87 |
| 2018-12-31 | 16.75 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
